Knight Therapeutics Inc. places No. 27 on The Globe and Mail's third-annual ranking of Canada's Top Growing Companies Medical Device Investing
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America Medical Device Investing
Sixth Wave Files for Non-Provisional Patent Protection on Its Affinity Technology Life Science Investing
U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges Medical Device Investing
Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis Medical Device Investing
Thermo Fisher Scientific to Present at the JP Morgan 12th Annual U.S. All Stars Conference on September 22, 2021 Medical Device Investing
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Medical Device Investing
Leveljump Healthcare Corp. Announces Voting Results of Annual and Special Meeting of Shareholders Medical Device Investing
Abbott Receives FDA Approval for Minimally Invasive Portico with FlexNav TAVR System to Treat Patients with Aortic Valve Disease Medical Device Investing
